0001213900-19-013470.txt : 20190724 0001213900-19-013470.hdr.sgml : 20190724 20190724161645 ACCESSION NUMBER: 0001213900-19-013470 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190724 DATE AS OF CHANGE: 20190724 EFFECTIVENESS DATE: 20190724 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TFF Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001733413 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 824344737 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-344985 FILM NUMBER: 19971122 BUSINESS ADDRESS: STREET 1: 2801 VIA FORTUNA, SUITE 425 CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: 737-802-1979 MAIL ADDRESS: STREET 1: 2801 VIA FORTUNA, SUITE 425 CITY: AUSTIN STATE: TX ZIP: 78746 D 1 primary_doc.xml X0708 D LIVE 0001733413 TFF Pharmaceuticals, Inc. 2600 VIA FORTUNA SUITE 360 AUSTIN TX TEXAS 78746 737-802-1979 DELAWARE None None Corporation true 2018 ROBERT S. MILLS, JR. 2600 VIA FORTUNA SUITE 360 AUSTIN TX TEXAS 78746 Director BRIAN WINDSOR 2600 VIA FORTUNA SUITE 360 AUSTIN TX TEXAS 78746 Director KIRK COLEMAN 2600 VIA FORTUNA SUITE 360 AUSTIN TX TEXAS 78746 Executive Officer AARON FLETCHER 2600 VIA FORTUNA SUITE 360 AUSTIN TX TEXAS 78746 Director GLENN MATTES 2600 VIA FORTUNA SUITE 360 AUSTIN TX TEXAS 78746 Executive Officer Director STEPHEN ROCAMBOLI 2600 VIA FORTUNA SUITE 360 AUSTIN TX TEXAS 78746 Director HARLAN WEISMAN 2600 VIA FORTUNA SUITE 360 AUSTIN TX TEXAS 78746 Director RANDY THURMAN 2600 VIA FORTUNA SUITE 360 AUSTIN TX TEXAS 78746 Director Pharmaceuticals Decline to Disclose 06b false 2019-05-16 false true false 10000 NATIONAL SECURITIES CORPORATION 7569 None None ONE UNION SQUARE 600 UNIVERSITY STREET, SUITE 2900 SEATTLE WA WASHINGTON 98101 AR ARKANSAS CA CALIFORNIA CO COLORADO CT CONNECTICUT DC DISTRICT OF COLUMBIA FL FLORIDA GA GEORGIA IL ILLINOIS IA IOWA MD MARYLAND MA MASSACHUSETTS MI MICHIGAN MN MINNESOTA MO MISSOURI NV NEVADA NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA OK OKLAHOMA PA PENNSYLVANIA TX TEXAS VA VIRGINIA WA WASHINGTON WI WISCONSIN false 8170000 8170000 0 false 229 817000 0 Represents 10% of the gross proceeds. The placement agent also received a warrant to purchase 10% of the number of shares of Series A Preferred Stock issued in the offering. 0 false TFF Pharmaceuticals, Inc. /s/ KIRK COLEMAN KIRK COLEMAN CHIEF FINANCIAL OFFICER 2019-07-15